Brokerages Set Calyxt (CLXT) PT at $29.05

Shares of Calyxt (NASDAQ:CLXT) have been given a consensus rating of “Hold” by the seven ratings firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating on the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $29.05.

Several brokerages have recently weighed in on CLXT. Zacks Investment Research cut shares of Calyxt from a “hold” rating to a “sell” rating in a research report on Friday, March 23rd. ValuEngine raised shares of Calyxt from a “sell” rating to a “hold” rating in a research report on Wednesday, March 14th. Jefferies Group reaffirmed a “buy” rating and issued a $27.00 target price on shares of Calyxt in a research report on Thursday, March 22nd. Finally, Ladenburg Thalmann Financial Services started coverage on shares of Calyxt in a research report on Wednesday, December 20th. They issued a “buy” rating and a $34.25 target price on the stock.

How to Become a New Pot Stock Millionaire

Shares of CLXT stock traded down $1.23 on Friday, hitting $14.79. 38,907 shares of the stock traded hands, compared to its average volume of 61,208. The company has a current ratio of 13.52, a quick ratio of 13.52 and a debt-to-equity ratio of 0.18. The stock has a market cap of $432.72 and a price-to-earnings ratio of -13.21. Calyxt has a twelve month low of $9.26 and a twelve month high of $31.89.

In other Calyxt news, CFO Bryan W.J. Corkal sold 19,600 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $20.73, for a total value of $406,308.00. Following the transaction, the chief financial officer now owns 92,300 shares of the company’s stock, valued at $1,913,379. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Alain Godard sold 6,125 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $20.70, for a total transaction of $126,787.50. Following the completion of the transaction, the director now directly owns 45,325 shares in the company, valued at approximately $938,227.50. The disclosure for this sale can be found here. Insiders sold 104,496 shares of company stock worth $2,045,928 in the last ninety days.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Schwab Charles Investment Management Inc. acquired a new stake in shares of Calyxt during the third quarter worth about $358,000. Bank of New York Mellon Corp acquired a new stake in shares of Calyxt during the third quarter worth about $542,000. California State Teachers Retirement System acquired a new stake in shares of Calyxt during the third quarter worth about $323,000. American International Group Inc. acquired a new stake in shares of Calyxt during the third quarter worth about $133,000. Finally, Deutsche Bank AG lifted its position in shares of Calyxt by 151.3% during the fourth quarter. Deutsche Bank AG now owns 18,378 shares of the company’s stock worth $404,000 after purchasing an additional 11,064 shares in the last quarter. 22.06% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another publication, it was illegally copied and republished in violation of U.S. & international copyright law. The original version of this report can be read at https://www.tickerreport.com/banking-finance/3336462/brokerages-set-calyxt-clxt-pt-at-29-05.html.

About Calyxt

Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans.

Analyst Recommendations for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

SmileyCoin Reaches Market Capitalization of $1.87 Million
SmileyCoin Reaches Market Capitalization of $1.87 Million
DeltaCredits Market Capitalization Reaches $0.00
DeltaCredits Market Capitalization Reaches $0.00
Reviewing Piedmont Office Realty Trust  & Sampo Group
Reviewing Piedmont Office Realty Trust & Sampo Group
Havven  Price Up 28% Over Last 7 Days
Havven Price Up 28% Over Last 7 Days
Head to Head Survey: Roper Technologies  & Mesa Laboratories
Head to Head Survey: Roper Technologies & Mesa Laboratories
Comparing PCM  & The Competition
Comparing PCM & The Competition


© 2006-2018 Ticker Report. Google+.